Drawing for ENVARSUS XR

USPTO serial 79165003

ENVARSUS XR

Reviewed by CopyMark Law Group

Reg. 4839039Status 707Registered
Filing date
Status date
Registration date
Oct 27, 2015
Examiner
REINHART, MEGHAN M
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ENVARSUS XR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia Anne Matheson

Julia Anne Matheson Potomac Law Group, PLLC1717 Pennsylvania Avenue, NWSuite 1025Washington, DC 20006

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, ] pills [, sachets, powders, capsules, all of the above ] for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy, ] immunology, [ burns, ] diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, ] diseases of the endocrinological system and pancreatic diseases, [ diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, nephrological diseases, [ diseases in the obstetrical and gynaecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and threat, diseases and afflictions in the psychiatric field, ] pulmonological diseases [ and afflictions, rheumatism, urological diseases and afflictions and generalized pain ]ACTIVE—
040[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, bio technical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]SECTION 71 - CANCELLED—
042[ Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, bio technical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries ]SECTION 71 - CANCELLED—
044[ Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 11, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 11, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 11, 202571.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Sep 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 30, 2025ES71TEAS SECTION 71 RECEIVED—
Nov 8, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 28, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 17, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 25, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
May 25, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 25, 2022C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
May 25, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 25, 2022REINREINSTATED—
May 24, 2022NC71NOTICE OF CANCELLATION SEC. 71 E-MAILED—
May 23, 2022C71TCANCELLED SECTION 71—
May 17, 2022EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Mar 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 22, 2021PUM1OFFICE ACTION ISSUED POU1—
Nov 17, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 26, 2021ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 18, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 21, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 27, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 7, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 21, 2018CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Aug 3, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jan 18, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 15, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 15, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 19, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 19, 2016FIMPFINAL DISPOSITION PROCESSED—
Jan 27, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 27, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 1, 2015CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Aug 21, 2015GPNXNOTIFICATION PROCESSED BY IB—
Aug 21, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 11, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 5, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 22, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 8, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 7, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 2, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 26, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 24, 2015ALIEASSIGNED TO LIE—
Jun 17, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 13, 2015RFNTREFUSAL PROCESSED BY IB—
May 26, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 26, 2015RFRRREFUSAL PROCESSED BY MPU—
May 24, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 23, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 16, 2015DOCKASSIGNED TO EXAMINER—
May 15, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 15, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 14, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance